Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response after Neoadjuvant Chemotherapy in Breast Cancer: model development using commonly available clinical and demographic variables

Author:

Jung Ji-Jung1ORCID,Kim Eun-Kyu2,Kang Eunyoung2,Kim Jee Hyun2,Kim Se Hyun2,Suh Koung Jin2,Kim Sun Mi2,Jang Mijung2,Yun Bo La2,Park So Yeon2,Lim Changjin3,Han Wonshik2,Shin Hee-Chul1ORCID

Affiliation:

1. Seoul National University Bundang Hospital

2. Seoul National University College of Medicine

3. Seoul National University Hospital

Abstract

Abstract Purpose Several predictive models have been developed to predict pathological complete response (pCR) after neoadjuvant chemotherapy (NAC), but few of them are broadly applicable due to radiologic complexity and institution-specific clinical variables, and none have been externally validated. The purpose of this study was to develop and externally validate a machine learning model that predicts pCR following NAC in breast cancer patients using routinely collected clinical and demographic variables. Methods Electronic medical record data of patients with advanced breast cancer who received NAC prior to surgical resection from January 2017 to December 2020 were reviewed. Patient data from Hospital A was split into training and internal validation cohort. Five machine learning techniques including gradient boosting machine, support vector machine, random forest, decision tree and neural network were used to build predictive models and area under the receiver-operating characteristic curve (AUC) were compared to select the best model. Finally, the model was further validated in an independent cohort from Hospital B. Results A total of 1003 patients were included in the study: 287 in the training cohort, 71 in the internal validation cohort, and 645 in the external validation cohort. Overall, 36.3% of patients achieved pCR. Among the five machine learning models, gradient boosting machine showed the highest AUC for pCR prediction (AUC 0.903, 95% CI 0.833–0.972). External validation confirmed AUC of 0.833 (95% CI 0.800-0.865). Conclusion We used commonly available clinical and demographic variables to develop a machine learning model to predict pCR following NAC. External validation of the model demonstrated good discrimination power, which showed that routinely collected variables are sufficient to build a good prediction model.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3